US Stock MarketDetailed Quotes

SONN Sonnet BioTherapeutic

Watchlist
  • 0.7501
  • +0.0489+6.97%
Close Aug 23 16:00 ET
  • 0.7205
  • -0.0296-3.95%
Post 19:45 ET
3.90MMarket Cap-6250P/E (TTM)

Sonnet BioTherapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Total revenue
0
0
-50.00%18.63K
-57.76%147.81K
-40.63%37.26K
-40.63%36.85K
-61.77%36.45K
-71.30%37.26K
-27.64%349.94K
-87.02%62.75K
Operating revenue
--0
--0
-50.00%18.63K
-57.76%147.81K
-40.63%37.26K
-40.63%36.85K
-61.77%36.45K
-71.30%37.26K
-27.64%349.94K
-87.02%62.75K
Cost of revenue
Gross profit
Operating expense
-10.72%3.53M
-32.14%3.87M
-77.03%1.3M
-36.91%18.94M
-51.11%3.64M
-50.16%3.95M
-31.36%5.7M
-10.96%5.65M
17.40%30.02M
0.12%7.44M
Selling and administrative expenses
16.79%1.8M
-9.73%1.7M
-65.67%653.46K
-16.90%7.13M
-22.50%1.79M
-32.35%1.54M
-0.83%1.88M
-8.43%1.9M
-4.04%8.58M
-3.30%2.32M
-General and administrative expense
16.79%1.8M
-9.73%1.7M
-65.67%653.46K
-16.90%7.13M
-22.50%1.79M
-32.35%1.54M
-0.83%1.88M
-8.43%1.9M
-4.04%8.58M
-3.30%2.32M
Research and development costs
-28.32%1.73M
-43.21%2.17M
-82.81%644.04K
-44.90%11.81M
-64.04%1.84M
-57.35%2.41M
-40.41%3.82M
-12.19%3.75M
28.91%21.44M
1.75%5.12M
Operating profit
9.88%-3.53M
31.71%-3.87M
77.21%-1.28M
36.66%-18.79M
51.20%-3.6M
50.23%-3.92M
31.00%-5.66M
9.70%-5.61M
-18.26%-29.67M
-6.19%-7.38M
Net non-operating interest income expense
Other net income (expense)
173.52%23.11K
183,946.55%4.23M
57.09%110.36K
23.64%-40.08K
-31.21%-76.59K
-220.93%-31.43K
-234.13%-2.3K
402.84%70.25K
-150.73%-52.48K
-1,021.75%-58.38K
Gain on sale of security
173.52%23.11K
-3,979.90%-93.96K
57.09%110.36K
23.64%-40.08K
-31.21%-76.59K
-220.93%-31.43K
-234.13%-2.3K
402.84%70.25K
-138.11%-52.48K
-1,021.75%-58.38K
Other non- operating income (expenses)
----
--4.33M
----
----
----
----
----
----
----
----
Income before tax
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
Income tax
Net income
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
Net income continuous Operations
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
Minority interest income
Net income attributable to the parent company
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
Basic earnings per share
76.27%-0.7
101.06%0.08
98.24%-0.31
87.95%-18.14
94.29%-2.1005
92.63%-2.95
82.03%-7.55
44.38%-17.62
51.99%-150.52
-3.49%-36.78
Diluted earnings per share
76.27%-0.7
100.93%0.07
98.24%-0.31
87.95%-18.14
94.29%-2.1005
92.63%-2.95
82.03%-7.55
44.38%-17.62
51.99%-150.52
-3.49%-36.78
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Total revenue 00-50.00%18.63K-57.76%147.81K-40.63%37.26K-40.63%36.85K-61.77%36.45K-71.30%37.26K-27.64%349.94K-87.02%62.75K
Operating revenue --0--0-50.00%18.63K-57.76%147.81K-40.63%37.26K-40.63%36.85K-61.77%36.45K-71.30%37.26K-27.64%349.94K-87.02%62.75K
Cost of revenue
Gross profit
Operating expense -10.72%3.53M-32.14%3.87M-77.03%1.3M-36.91%18.94M-51.11%3.64M-50.16%3.95M-31.36%5.7M-10.96%5.65M17.40%30.02M0.12%7.44M
Selling and administrative expenses 16.79%1.8M-9.73%1.7M-65.67%653.46K-16.90%7.13M-22.50%1.79M-32.35%1.54M-0.83%1.88M-8.43%1.9M-4.04%8.58M-3.30%2.32M
-General and administrative expense 16.79%1.8M-9.73%1.7M-65.67%653.46K-16.90%7.13M-22.50%1.79M-32.35%1.54M-0.83%1.88M-8.43%1.9M-4.04%8.58M-3.30%2.32M
Research and development costs -28.32%1.73M-43.21%2.17M-82.81%644.04K-44.90%11.81M-64.04%1.84M-57.35%2.41M-40.41%3.82M-12.19%3.75M28.91%21.44M1.75%5.12M
Operating profit 9.88%-3.53M31.71%-3.87M77.21%-1.28M36.66%-18.79M51.20%-3.6M50.23%-3.92M31.00%-5.66M9.70%-5.61M-18.26%-29.67M-6.19%-7.38M
Net non-operating interest income expense
Other net income (expense) 173.52%23.11K183,946.55%4.23M57.09%110.36K23.64%-40.08K-31.21%-76.59K-220.93%-31.43K-234.13%-2.3K402.84%70.25K-150.73%-52.48K-1,021.75%-58.38K
Gain on sale of security 173.52%23.11K-3,979.90%-93.96K57.09%110.36K23.64%-40.08K-31.21%-76.59K-220.93%-31.43K-234.13%-2.3K402.84%70.25K-138.11%-52.48K-1,021.75%-58.38K
Other non- operating income (expenses) ------4.33M--------------------------------
Income before tax 11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M
Income tax
Net income 11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M
Net income continuous Operations 11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M
Minority interest income
Net income attributable to the parent company 11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M
Basic earnings per share 76.27%-0.7101.06%0.0898.24%-0.3187.95%-18.1494.29%-2.100592.63%-2.9582.03%-7.5544.38%-17.6251.99%-150.52-3.49%-36.78
Diluted earnings per share 76.27%-0.7100.93%0.0798.24%-0.3187.95%-18.1494.29%-2.100592.63%-2.9582.03%-7.5544.38%-17.6251.99%-150.52-3.49%-36.78
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg